immunotherapy /saigenci/ en SAiGENCI researcher awarded funding in latest MRFF round /saigenci/news/list/2025/04/08/saigenci-researcher-awarded-funding-in-latest-mrff-round A SAiGENCI project using nanotechnology has received funding in the latest round of Medical ÌÇÐÄvolg Future Fund (MRFF) Early-to-Mid Career ÌÇÐÄvolgers funding. April 08 2025 Debbie Wellington /saigenci/news/list/2025/04/08/saigenci-researcher-awarded-funding-in-latest-mrff-round SAiGENCI recruit recognised with prestigious award /saigenci/news/list/2023/05/18/saigenci-recruit-recognised-with-prestigious-award Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South Australian ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the University of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN). May 18 2023 Debbie Wellington /saigenci/news/list/2023/05/18/saigenci-recruit-recognised-with-prestigious-award